1. Home
  2. BYND vs CCCC Comparison

BYND vs CCCC Comparison

Compare BYND & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • CCCC
  • Stock Information
  • Founded
  • BYND 2009
  • CCCC 2015
  • Country
  • BYND United States
  • CCCC United States
  • Employees
  • BYND N/A
  • CCCC N/A
  • Industry
  • BYND Packaged Foods
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYND Consumer Staples
  • CCCC Health Care
  • Exchange
  • BYND Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • BYND 183.2M
  • CCCC 175.1M
  • IPO Year
  • BYND 2019
  • CCCC 2020
  • Fundamental
  • Price
  • BYND $2.49
  • CCCC $2.70
  • Analyst Decision
  • BYND Sell
  • CCCC Buy
  • Analyst Count
  • BYND 4
  • CCCC 3
  • Target Price
  • BYND $3.67
  • CCCC $8.00
  • AVG Volume (30 Days)
  • BYND 2.2M
  • CCCC 1.3M
  • Earning Date
  • BYND 11-05-2025
  • CCCC 10-30-2025
  • Dividend Yield
  • BYND N/A
  • CCCC N/A
  • EPS Growth
  • BYND N/A
  • CCCC N/A
  • EPS
  • BYND N/A
  • CCCC N/A
  • Revenue
  • BYND $301,353,000.00
  • CCCC $34,240,000.00
  • Revenue This Year
  • BYND N/A
  • CCCC N/A
  • Revenue Next Year
  • BYND $0.73
  • CCCC N/A
  • P/E Ratio
  • BYND N/A
  • CCCC N/A
  • Revenue Growth
  • BYND N/A
  • CCCC 16.55
  • 52 Week Low
  • BYND $2.23
  • CCCC $1.09
  • 52 Week High
  • BYND $7.60
  • CCCC $7.22
  • Technical
  • Relative Strength Index (RSI)
  • BYND 42.66
  • CCCC 58.97
  • Support Level
  • BYND $2.29
  • CCCC $2.33
  • Resistance Level
  • BYND $2.70
  • CCCC $2.85
  • Average True Range (ATR)
  • BYND 0.13
  • CCCC 0.19
  • MACD
  • BYND 0.02
  • CCCC -0.01
  • Stochastic Oscillator
  • BYND 51.44
  • CCCC 64.49

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: